Erschienen in:
24.06.2020 | Concise Research Report
Adoption and Trends in the Medicare New Technology Add-On Payment Program
verfasst von:
Jacob R. Morey, MBA, Margaret Katana, MPH, Lihua Li, PhD, Sam Hohmann, PhD, Ellerie Weber, PhD, Bart Ferket, MD, PhD
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 7/2021
Einloggen, um Zugang zu erhalten
Excerpt
In 2001, the Centers for Medicare and Medicaid Services (CMS) introduced the New Technology Add-on Payment (NTAP) program to incentivize utilization of new inpatient technologies in the Medicare population. Technologies are eligible for NTAP if they (1) are new (within 2–3 years of market introduction), (2) substantially improve the diagnosis or treatment relative to currently available technologies, and (3) are inadequately paid otherwise under the current diagnosis-related group (DRG) reimbursement rates.
1 Technologies are eligible for a duration of 1–2 years, until the DRG reimbursement rate is recalculated. …